These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29635719)

  • 21. Predicting the duration of Guam amyotrophic lateral sclerosis.
    Reed DM; Brody JA; Holden EM
    Neurology; 1975 Mar; 25(3):277-80. PubMed ID: 1167636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality rate of amyotrophic lateral sclerosis in Japan: effects of marital status and social class, and geographical variation.
    Imaizumi Y
    Jinrui Idengaku Zasshi; 1986 Jun; 31(2):101-11. PubMed ID: 3820769
    [No Abstract]   [Full Text] [Related]  

  • 23. Nutritional assessment of amyotrophic lateral sclerosis in routine practice: value of weighing and bioelectrical impedance analysis.
    Roubeau V; Blasco H; Maillot F; Corcia P; Praline J
    Muscle Nerve; 2015 Apr; 51(4):479-84. PubMed ID: 25130859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypermetabolism appears to be an adverse prognostic biomarker in amyotrophic lateral sclerosis: a potential for therapeutic intervention?
    Vucic S
    Eur J Neurol; 2018 Jan; 25(1):1-2. PubMed ID: 28940741
    [No Abstract]   [Full Text] [Related]  

  • 25. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.
    Van Laere K; Vanhee A; Verschueren J; De Coster L; Driesen A; Dupont P; Robberecht W; Van Damme P
    JAMA Neurol; 2014 May; 71(5):553-61. PubMed ID: 24615479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to the letter 'Type 2 diabetes and amyotrophic lateral sclerosis'.
    Mariosa D; Fang F
    Eur J Neurol; 2016 Apr; 23(4):e26. PubMed ID: 27000982
    [No Abstract]   [Full Text] [Related]  

  • 27. Commentary: Amyotrophic lateral sclerosis: Ongoing search for prognostic biomarkers of longevity.
    Pandey S; Sarma N
    Neurol India; 2017; 65(5):1155-1156. PubMed ID: 28879922
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prognostic factors in amyotrophic lateral sclerosis].
    Ramelli E
    Acta Neurol (Napoli); 1970; 25(4):441-9. PubMed ID: 5505433
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognosis in amyotrophic lateral sclerosis: a population-based study.
    del Aguila MA; Longstreth WT; McGuire V; Koepsell TD; van Belle G
    Neurology; 2003 Mar; 60(5):813-9. PubMed ID: 12629239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease.
    Mitchell JD; Wokke JH; Borasio GD
    Cochrane Database Syst Rev; 2002; (3):CD002064. PubMed ID: 12137643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reply to: The Letter to be published with the Letter, Amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD) syndrome as a phenotype of Creutzfeldt-Jakob disease (CJD)? A case report.
    Yaguchi H; Takeuchi A; Horiuchi K; Takahashi I; Shirai S; Akimoto S; Satoh K; Moriwaka F; Yabe I; Sasaki H
    J Neurol Sci; 2017 Apr; 375():490-491. PubMed ID: 28259353
    [No Abstract]   [Full Text] [Related]  

  • 32. Author response to a Letter to the Editor entitled: Edaravone administration in pivotal clinical study 19 (Authors: Genge, Angela; Brooks, Benjamin).
    Turnbull J
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):300-302. PubMed ID: 31074645
    [No Abstract]   [Full Text] [Related]  

  • 33. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis.
    Walker AK; Farg MA; Bye CR; McLean CA; Horne MK; Atkin JD
    Brain; 2010 Jan; 133(Pt 1):105-16. PubMed ID: 19903735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Histopathology of the central nervous system in amyotrophic lateral sclerosis. III. Inflammatory factor of amyotrophic lateral sclerosis].
    KHONDKARIAN OA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1955; 55(10):755-8. PubMed ID: 13300956
    [No Abstract]   [Full Text] [Related]  

  • 35. Response to letter to the editor.
    Rafiq MK
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):481. PubMed ID: 23721564
    [No Abstract]   [Full Text] [Related]  

  • 36. Response to "Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis" by Kumar et al.
    Chakraborty S
    Clin Chim Acta; 2010 Sep; 411(17-18):1382; author reply 1383. PubMed ID: 20478286
    [No Abstract]   [Full Text] [Related]  

  • 37. [CLINICAL ASPECTS OF PROLONGED FORMS OF AMYOTROPHIC LATERAL SCLEROSIS].
    BOUDOURESQUES J; KHALIL R
    Gaz Med Fr; 1964 Mar; 71():849-54. PubMed ID: 14142817
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
    Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
    Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Commentary on the Article 'Healing of Amyotrophic Lateral Sclerosis: A Case Report' by Mangelsdorf et al.].
    Naumann J
    Complement Med Res; 2017; 24(3):182. PubMed ID: 28641296
    [No Abstract]   [Full Text] [Related]  

  • 40. Sporadic Parkinson disease and amyotrophic lateral sclerosis complex (Brait-Fahn-Schwartz disease).
    Manno C; Lipari A; Bono V; Taiello AC; La Bella V
    J Neurol Sci; 2013 Mar; 326(1-2):104-6. PubMed ID: 23380453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.